Seitz Michelle

Seitz Michelle is listed in filings as Director at Sana Biotechnology, Inc.. This profile follows SEC Form 4 activity through Jun 5, 2026, including 7 public disclosures. Recent filings connect the profile to Sana Biotechnology, Inc. (SANA), MSCI Inc (MSCI), and Metlife inc CMN (2020 Irrev Trust FBO Grandchildren) (MET). The current snapshot covers public activity from Aug 7, 2024 to Jun 5, 2026. Reported amounts are shown as $266.4K to $204.0K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.